Potential roles of insulin and IGF-1 in Alzheimer's disease

被引：224
|
作者：
Gasparini, L
Xu, HX
机构：
[1] Nicox Res Inst, I-20091 Milan, Italy
[2] Rockefeller Univ, Fisher Ctr Res Alzheimer Dis, New York, NY 10021 USA
来源：
TRENDS IN NEUROSCIENCES | 2003年 / 26卷 / 08期
关键词：
D O I：
10.1016/S0166-2236(03)00163-2
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Aging is characterized by a significant decline of metabolic and hormonal functions, which often facilitates the onset of severe age-associated pathologies. One outstanding example of this is the reported association of deranged signaling by insulin and insulin-like-growth-factor 1 (IGF-1) with Alzheimer's disease (AD). Recent compelling biological data reveal effects of insulin and IGF-1 on molecular and cellular mechanisms underlying the pathology of AD. This review discusses available biological data that highlight the therapeutic potential of the insulin-IGF-1 signaling pathway in AD.
引用
收藏
页码：404 / 406
页数：3
相关论文
共 50 条
  • [1] Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease
    O'Neill, Cora
    Kiely, Aoife P.
    Coakley, Meghan F.
    Manning, Sean
    Long-Smith, Caitriona M.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 721 - 727
  • [2] Beta-Amyloid Monomer and Insulin/IGF-1 Signaling in Alzheimer's Disease
    Giuffrida, Maria Laura
    Tomasello, Flora
    Caraci, Filippo
    Chiechio, Santina
    Nicoletti, Ferdinando
    Copani, Agata
    [J]. MOLECULAR NEUROBIOLOGY, 2012, 46 (03) : 605 - 613
  • [3] Beta-Amyloid Monomer and Insulin/IGF-1 Signaling in Alzheimer's Disease
    Maria Laura Giuffrida
    Flora Tomasello
    Filippo Caraci
    Santina Chiechio
    Ferdinando Nicoletti
    Agata Copani
    [J]. Molecular Neurobiology, 2012, 46 : 605 - 613
  • [4] Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
    Moloney, Aileen M.
    Griffin, Rebecca J.
    Timmons, Suzanne
    O'Connor, Rosemary
    Ravid, Rivka
    O'Neill, Cora
    [J]. NEUROBIOLOGY OF AGING, 2010, 31 (02) : 224 - 243
  • [5] Abnormalities in insulin, IGF-1, and corresponding receptor (R) expression in Alzheimer's disease.
    Terry, BM
    Cannon, JC
    Guong, L
    Wands, JR
    de la Monte, SM
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 546 - 546
  • [6] Severity of dementia in Alzheimer's disease depends on IGF-1 level but not on IGF-1 promoter polymorphism
    Geppert, A. M.
    Koczorowska, M.
    Gozdzicka-Jozefiak, A.
    Przedpelska-Ober, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 181 - 181
  • [7] Insulin-Like Growth Factor 1 (IGF-1) and Risk of Alzheimer's Disease: The Framingham Study
    Westwood, Andrew J.
    Baiser, Alexa S.
    Vasan, Ramachandran S.
    Harris, Tamara B.
    Roubenoff, Ronenn
    Pikula, Aleksandra
    Au, Rhoda
    DeCarli, Charles
    Wolf, Philip A.
    Seshadri, Sudha
    [J]. ANNALS OF NEUROLOGY, 2011, 70 : S51 - S51
  • [8] The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimer's Disease: From Model Organisms to Human Disease
    Freude, S.
    Schilbach, K.
    Schubert, M.
    [J]. CURRENT ALZHEIMER RESEARCH, 2009, 6 (03) : 213 - 223
  • [9] Donepezil May Reduce Insulin-Like Growth Factor-1 (IGF-1) Levels in Alzheimer's disease
    Ala, Tom
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (01) : 108 - 112
  • [10] Insulin, IGF-1 and longevity
    van Heemst, Diana
    [J]. AGING AND DISEASE, 2010, 1 (02): : 147 - 157
12345